Abernethy Matt
Reporting Owner SEC Filing List
CIK: 0001724097
| Form | Filer | Subject Company | Filing Agent | Date | Actions | ||
|---|---|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Neurocrine Biosciences Inc | 03/05/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Abernethy Matt | 03/05/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Neurocrine Biosciences Inc | 02/17/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Abernethy Matt | 02/17/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Neurocrine Biosciences Inc | 02/03/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Abernethy Matt | 02/03/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Fate Therapeutics Inc | Donnelley Financial Solutions /fa | 05/30/2025 | |||
| 3 | Initial statement of beneficial ownershi... | Fate Therapeutics Inc | Donnelley Financial Solutions /fa | 05/30/2025 | |||
| 4 | Statement of changes in beneficial owner... | Neurocrine Biosciences Inc | Neurocrine Biosciences Inc /fa | 02/14/2025 | |||
| 144 | Filing for proposed sale of securities u... | Neurocrine Biosciences Inc | Morgan Stanley Smith Barney Llc Executive Services /fa | 02/13/2025 | |||
| Load More | |||||||
Abernethy Matt 's Ownership Transactions
| Issuer | Filing Date | Transaction Date | Transaction Type | Shares | Price | Total Amt | Shares Owned |
|---|
